Described herein are pharmaceutical packaging methods which avert oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-sensitive prescription drugs, these methods which include a syringe using an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with very small permeability to oxygen